As per MRFR analysis, the US Kidney Stones Market Size was estimated at 546 (USD Million) in 2023.
The US Kidney Stones Market Industry is expected to grow from 600(USD Million) in 2024 to 1,100 (USD Million) by 2035. The US Kidney Stones Market CAGR (growth rate) is expected to be around 5.665% during the forecast period (2025 - 2035).
The US Kidney Stones Market is undergoing some important shifts due to the rising prevalence of kidney stones, particularly in adults. This increase is attributed to a number of reasons, including changes in diet, high obesity rates, and other lifestyle factors.
The use of advanced imaging methods and minimally invasive surgical techniques has additionally changed the treatment paradigm, allowing for quicker recovery and shorter hospital stays. This technological change is a major driver of the market, as it boosts recovery outcomes and patient satisfaction. This shift attracts more providers to these solutions. There are amazing gaps to be filled in the US Market especially in the form of preventive measures and personal health management technologies.
Nutrition counselling combined with hydration services will likely grow in popularity as proactively caring for one’s health becomes more prioritized. Also, the incorporation of telehealth services offers a novel opportunity to improve education and patient participation around the prevention and management of kidney stones, in accordance with the increase of the digital health trend in the United States healthcare system.
Recently, there has been initiative shift towards initiative-taking healthcare primarily from healthcare and public health institutions. More campaigns promoting knowledge related to kidney stones, their underlying factors, and management techniques are emerging.
Alongside this, the promotion of healthy changes and living also significantly homes in on Americans. Therefore, this provides an additional opportunity for a broad range of stakeholders within the healthcare system to devise initiatives aimed at reducing the risk factors driving the prevalence of kidney stones for better population health.
The US Kidney Stones Market Industry is witnessing significant growth due to the increasing incidence of kidney stones among the population. According to the National Institute of Diabetes and Digestive and Kidney Diseases, approximately 1 in 10 Americans will develop a kidney stone in their lifetime. This statistic highlights a growing health concern that can drive the market forward as more individuals seek effective treatments and preventive measures.
In addition, data from the American Urological Association indicates that the prevalence of kidney stones has nearly doubled in the last 30 years, particularly affecting individuals aged 30 to 60. This demographic shift presents a growing market opportunity for healthcare providers and pharmaceutical companies focused on developing innovative treatments for kidney stones. The accelerating rates of obesity and metabolic syndrome in the US population, which contribute to the formation of kidney stones, further emphasize the potential for market growth in this sector.
With increased awareness and advancements in technology, the demand for diagnostic and treatment options related to kidney stones is anticipated to surge significantly impacting the US Kidney Stones Market Industry.
The US Kidney Stones Market Industry is experiencing robust growth due to ongoing advancements in medical technology, particularly in diagnostic and treatment options. The introduction of minimally invasive procedures such as ureteroscopy and shock wave lithotripsy has revolutionized the treatment of kidney stones, increasing patient comfort and recovery times.
The American Urological Association emphasizes that these innovative procedures lead to higher success rates and lower complication rates, which are critical factors driving adoption among both patients and healthcare providers. Additionally, technological advancements in imaging techniques such as CT scans and ultrasounds enable earlier diagnosis and intervention, further enhancing treatment outcomes.
As a result, leading medical manufacturers and organizations are investing in Research and Development (R&D) to improve these technologies, solidifying growth prospects within the market.
Another significant driver contributing to the growth of the US Kidney Stones Market Industry is the rising awareness among the population regarding kidney health and preventive care. Public health campaigns led by organizations like the National Kidney Foundation are emphasizing the importance of maintaining hydration and dietary modifications to prevent kidney stone formation.
Such awareness initiatives have resulted in increased screenings and preventive strategies among high-risk populations, particularly those with a history of kidney stones. According to the Centers for Disease Control and Prevention, the number of individuals receiving preventive care services has risen, reflecting a shift towards proactive health management.
This growing inclination toward preventive measures is likely to bolster the demand for dietary supplements, medications, and educational resources associated with kidney stones, propelling market expansion.
The Type segment of the US Kidney Stones Market encompasses a variety of kidney stone compositions, each with unique clinical implications and treatment approaches. Among these, Calcium Oxalate Stones represent the most prevalent form, often associated with dietary factors and dehydration, which are significant health concerns in the United States, particularly due to modern lifestyle choices.
The presence of Uric Acid stones is of particular interest, primarily linked to dietary habits, metabolic conditions, and obesity, highlighting a growing need for public awareness regarding nutrition and its direct impact on kidney stone formation. Struvite Kidney Stones, often resultant from urinary tract infections, indicate a different health pathway, emphasizing the importance of managing urinary health to prevent such occurrences.
Cystine Stones, while less common, are crucial due to their genetic predispositions, requiring targeted interventions and personalized treatment plans for affected patients. Additionally, Calcium Phosphate Stones, which are usually associated with metabolic disorders, underscore the importance of early diagnosis and proper management of underlying health conditions to mitigate the risk of stone formation.
These various types of kidney stones reflect significant segments in the US Kidney Stones Market, each demonstrating a unique prevalence, associated health risks, and treatment considerations that influence both healthcare practices and patient management strategies. Awareness and education regarding the different types of kidney stones can drive market growth and improve patient outcomes, paving the way for innovative approaches in treatment and prevention in the future.
The Treatment Type segment of the US Kidney Stones Market plays a crucial role in addressing the needs of patients experiencing kidney stones, which are a prevalent health issue in the United States. Various treatment options, such as Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithotomy, offer diverse approaches tailored to the severity and characteristics of the condition.
Medications often serve as an initial management strategy to alleviate pain and facilitate stone passage. Extracorporeal Shock Wave Lithotripsy is prominent for its non-invasive nature, efficiently targeting stones with minimal recovery time, thus catering to a large population seeking less invasive treatment options.
Ureteroscopy enables direct visualization and removal of stones, providing physicians with operational flexibility while ensuring patient safety. Percutaneous Nephrolithotomy is noteworthy for its effectiveness in managing larger stones, where other treatments may fall short. The ongoing advancements and effectiveness of these treatment strategies contribute significantly to the overall US Kidney Stones Market revenue, aligning with a growing demand for efficient and patient-centric solutions in urological care.
The increasing prevalence of kidney stones in the US underscores the importance of these treatment types in addressing public health challenges and enhancing patient outcomes.
The Diagnosis segment of the US Kidney Stones Market is vital in the overall management and treatment of kidney stones, showcasing significant growth driven by advancements in medical technology and increasing awareness among patients. Different diagnostic methods, including Ultrasound, Intravenous Pyelography, CT scan, and X-Ray, collectively contribute to accurate detection and assessment of kidney stones, allowing for timely intervention.
Ultrasound is noted for its non-invasive nature and reduced radiation exposure, making it popular among physicians and patients. The Intravenous Pyelography method is traditionally significant for its detailed visualization of urinary tract structures, enhancing diagnosis accuracy.
CT scans are highly regarded for their precision in detecting even small stones, thus dominating the diagnostic landscape. X-Ray still plays a role but is less emphasized in complex cases. The US Kidney Stones Market statistics highlight that the rising prevalence of kidney stones, coupled with an aging population and lifestyle changes, is propelling demand for innovative diagnostic solutions that not only improve patient outcomes but also streamline healthcare processes.
As the healthcare industry continues to evolve, opportunities for enhancing diagnostic efficiency and patient care in the US Kidney Stones Market remain abundant.
The US Kidney Stones Market has seen significant growth driven by the increasing incidence of kidney stones, technological advancements in the diagnostic and therapeutic procedures, and a rising awareness of preventive health measures. The competitive landscape is characterized by a diverse array of players ranging from established multinational corporations to specialized niche companies. This market is influenced by various factors including regulatory approvals, access to cutting-edge technologies, and collaborative ventures.
As healthcare continues to evolve, companies are prioritizing innovations that enhance patient outcomes while also focusing on cost-efficiency. The growing prevalence of kidney stones has prompted extensive research and development efforts aimed at improving treatment protocols and reducing the need for invasive procedures. As a result, competition is intensifying, with firms striving to establish their market presence through strategic partnerships and acquisitions, broadening their product portfolios, and enhancing their brand visibility.
Olympus Corporation maintains a robust presence in the US Kidney Stones Market through its advanced medical technology and a strong commitment to innovation. Known for their high-quality endoscopic equipment, Olympus has established a reputation for offering effective solutions for the diagnosis and treatment of kidney stones, such as ureteroscopy and laser lithotripsy systems. Its strengths in the market lie in its comprehensive range of products, which cater to various clinical needs, ensuring that healthcare providers have access to the latest technology for patient care. Moreover, Olympus benefits from significant investments in research and development, enabling it to stay ahead of competitors in delivering cutting-edge solutions. The company's focus on user-friendly and reliable products has garnered strong clinician trust, further solidifying Olympus's competitive position in the US market.
Coloplast has also made a notable impact in the US Kidney Stones Market with its innovative offerings designed for both prevention and treatment of kidney stones. The company specializes in various medical devices and services, including catheter solutions and drainage systems, which are crucial for managing patients with urinary tract conditions. Coloplast's strengths lie in its commitment to patient-centric healthcare, providing educational resources and support services that improve patient outcomes. The company has focused on mergers and acquisitions that expand its product lines, allowing it to leverage synergies and enhance its operational efficiency within the region. By forging strategic alliances and maintaining high-quality standards, Coloplast has successfully positioned itself within the competitive landscape of the US Kidney Stones Market, catering to healthcare professionals with effective solutions tailored to meet the growing demands in kidney stone management.
The US Kidney Stones Market has seen significant developments recently, driven by advancements in technology and increasing prevalence of kidney stones. In September 2023, Olympus Corporation announced the launch of a new endoscopic device designed for better management of kidney stones, showcasing innovation in minimally invasive treatments. Meanwhile, Coloplast is focusing on expanding its product line to cater to the rising demand for less invasive procedures, aligning with current patient preferences.
In terms of mergers, in August 2023, Medtronic acquired Mazor Robotics, enhancing its capabilities in robotic-assisted surgery, which could benefit kidney stone treatment protocols. Additionally, Boston Scientific's recent partnership with UroLift in July 2023 aims to broaden access to urinary health solutions, indirectly impacting the kidney stones segment.
The overall market has experienced a shift towards more technologically-driven solutions, with companies like Stryker and Johnson and Johnson enhancing their Research and Development efforts to provide state-of-the-art solutions for kidney stone management. Joslin Diabetes Center statistics show that the incidence of kidney stones continues to rise, influencing market demand and encouraging companies to innovate in treatment approaches.
| Report Attribute/Metric | Details |
| Market Size 2023 | 546.0 (USD Million) |
| Market Size 2024 | 600.0 (USD Million) |
| Market Size 2035 | 1100.0 (USD Million) |
| Compound Annual Growth Rate (CAGR) | 5.665% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Olympus Corporation, Coloplast, Allergan, Cook Medical, Karl Storz, Boston Scientific, Stryker, UroLift, Johnson & Johnson, Auris Health, Medtronic, Varian Medical Systems, CooperSurgical, C.R. Bard, Teleflex |
| Segments Covered | Type, Treatment Type, Diagnosis |
| Key Market Opportunities | Innovative non-invasive treatments, Advanced imaging technologies, Increasing awareness campaigns, Digital health solutions, Personalized dietary interventions |
| Key Market Dynamics | rising prevalence of kidney stones, increasing awareness and education, advancements in treatment technologies, aging population, healthcare cost considerations |
| Countries Covered | US |
Frequently Asked Questions (FAQ) :
The US Kidney Stones Market was valued at 600.0 USD Million by the year 2024.
By 2035, the US Kidney Stones Market is anticipated to reach a valuation of 1100.0 USD Million.
The expected CAGR for the US Kidney Stones Market from 2025 to 2035 is 5.665 percent.
Calcium Oxalate Stones is projected to dominate the US Kidney Stones Market with a value of 450.0 USD Million by 2035.
Key players in the US Kidney Stones Market include Olympus Corporation, Coloplast, Allergan, Cook Medical, and Johnson & Johnson, among others.
The Uric Acid segment of the US Kidney Stones Market is expected to be valued at 175.0 USD Million in 2035.
The market size for Struvite Kidney Stones is projected to reach 150.0 USD Million by 2035.
The US Kidney Stones Market may face challenges such as increasing healthcare costs and evolving regulatory landscapes.
The Calcium Phosphate Stones market is expected to be valued at 195.0 USD Million by 2035.
The growth of the US Kidney Stones Market is driven by an increasing prevalence of kidney stones and advancements in treatment technologies.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
